Clinical trials in Palo Alto, CA

124 recruiting studies have a site in or near Palo Alto, CA, California.

Top conditions here

All conditions

Showing 40 of 124 studies

RecruitingPhase 3NCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Palo Alto, CA · +22 more sites

RecruitingPhase 3NCT06136650

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Sponsor: Merck Sharp & Dohme LLC

Irvine, CA · Los Angeles, CA · Orange, CA · +60 more sites

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Antioch, CA · Arroyo Grande, CA · Burbank, CA · +452 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1147 more sites

RecruitingPhase 1NCT07304154

Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

Sponsor: Kite, A Gilead Company

Newport Beach, CA · Palo Alto, CA · +3 more sites

RecruitingPhase 1NCT06879041

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: AstraZeneca

Palo Alto, CA · San Diego, CA · +10 more sites

RecruitingPhase 1NCT07139743

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Sponsor: Autolus Limited

Palo Alto, CA

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

Auburn, CA · Berkeley, CA · Beverly Hills, CA · +200 more sites

RecruitingPhase 1NCT05188170

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Sponsor: Stanford University

Palo Alto, CA

RecruitingPhase not listedNCT07616856

Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry

Sponsor: Lumicell, Inc.

Palo Alto, CA

RecruitingPhase 1 / Phase 2NCT06137118

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Sponsor: AstraZeneca

Duarte, CA · Los Angeles, CA · Palo Alto, CA · +9 more sites

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Duarte, CA · Irvine, CA · La Jolla, CA · +60 more sites

RecruitingPhase 1 / Phase 2NCT04065399

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Sponsor: Syndax Pharmaceuticals

Duarte, CA · Los Angeles, CA · Palo Alto, CA · +19 more sites

RecruitingPhase 2NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Auburn, CA · Baldwin Park, CA · +275 more sites

RecruitingNot applicableNCT06685211

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

Sponsor: Stanford University

Palo Alto, CA

RecruitingPhase 3NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Sponsor: AstraZeneca

Inglewood, CA · Los Angeles, CA · Palo Alto, CA · +77 more sites

RecruitingPhase 3NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Sponsor: SWOG Cancer Research Network

Antioch, CA · Clovis, CA · +331 more sites

RecruitingPhase 3NCT06976203

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Sponsor: Bristol-Myers Squibb

Fullerton, CA · Irvine, CA · Los Angeles, CA · +28 more sites

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Clovis, CA · Duarte, CA · Emeryville, CA · +126 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Berkeley, CA · Encinitas, CA · +251 more sites

RecruitingPhase 2NCT07589595

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Sponsor: Eli Lilly and Company

Carlsbad, CA · Irvine, CA · La Jolla, CA · +39 more sites

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Los Angeles, CA · Palo Alto, CA · San Francisco, CA · +28 more sites

RecruitingPhase 1NCT05997615

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Sponsor: Astellas Pharma Global Development, Inc.

Duarte, CA · Irvine, CA · Orange, CA · +5 more sites

RecruitingNot applicableNCT06080061

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

Sponsor: Stanford University

Palo Alto, CA · San Jose, CA

RecruitingNot applicableNCT07864168

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

Sponsor: Medtronic MiniMed, Inc.

Chula Vista, CA · Palo Alto, CA · San Diego, CA · +15 more sites

RecruitingPhase 3NCT06790693

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Sponsor: Hoffmann-La Roche

Burbank, CA · Irvine, CA · La Jolla, CA · +59 more sites

RecruitingPhase 3NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Sponsor: Hoffmann-La Roche

Fullerton, CA · La Jolla, CA · Los Angeles, CA · +50 more sites

RecruitingNot applicableNCT07403981

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

Sponsor: Stanford University

Palo Alto, CA

RecruitingPhase 2NCT07405801

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Sponsor: Hoffmann-La Roche

Anaheim, CA · Palo Alto, CA · +8 more sites

RecruitingPhase 2NCT07432958

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Sponsor: Appello Pharmaceuticals, Inc.

Carlsbad, CA · Los Alamitos, CA · Los Angeles, CA · +27 more sites

RecruitingPhase 1NCT03816345

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI)

Palo Alto, CA · Sacramento, CA · +49 more sites

RecruitingPhase 1NCT06840886

A Study of PHST001 in Advanced Solid Tumors

Sponsor: Pheast Therapeutics

Beverly Hills, CA · Los Angeles, CA · Palo Alto, CA · +17 more sites

RecruitingPhase 3NCT06982521

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Sponsor: Relay Therapeutics, Inc.

Beverly Hills, CA · Duarte, CA · Los Angeles, CA · +49 more sites

RecruitingPhase 1NCT07306832

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Sponsor: AbbVie

Palo Alto, CA · +4 more sites

RecruitingPhase 2NCT05104983

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Sponsor: Darcy Krueger

Los Angeles, CA · Palo Alto, CA · +9 more sites

RecruitingPhase 2NCT06680830

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Sponsor: Neuron23 Inc.

Fresno, CA · Irvine, CA · Los Angeles, CA · +42 more sites

RecruitingPhase 1NCT05176483

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Sponsor: Exelixis

Palo Alto, CA · Santa Barbara, CA · +44 more sites

RecruitingPhase 3NCT07221851

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Sponsor: Ascendis Pharma A/S

Palo Alto, CA · Sacramento, CA · +21 more sites

RecruitingPhase 1 / Phase 2NCT06619990

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Sponsor: Xencor, Inc.

Palo Alto, CA · +29 more sites

RecruitingPhase 3NCT07277231

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Sponsor: BeOne Medicines

Duarte, CA · Orange, CA · Palo Alto, CA · +19 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.